Ascendis Pharma A (ASND) Receivables Refunds (2016 - 2025)
Historic Receivables Refunds for Ascendis Pharma A (ASND) over the last 12 years, with Q3 2025 value amounting to $3.4 million.
- Ascendis Pharma A's Receivables Refunds rose 5666.03% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 5666.03%. This contributed to the annual value of $1.9 million for FY2024, which is 12263.78% up from last year.
- Per Ascendis Pharma A's latest filing, its Receivables Refunds stood at $3.4 million for Q3 2025, which was up 5666.03% from $3.1 million recorded in Q2 2025.
- In the past 5 years, Ascendis Pharma A's Receivables Refunds registered a high of $3.4 million during Q3 2025, and its lowest value of $806080.6 during Q1 2024.
- For the 5-year period, Ascendis Pharma A's Receivables Refunds averaged around $1.6 million, with its median value being $1.6 million (2022).
- Over the last 5 years, Ascendis Pharma A's Receivables Refunds had its largest YoY gain of 11981.09% in 2024, and its largest YoY loss of 2941.72% in 2024.
- Over the past 5 years, Ascendis Pharma A's Receivables Refunds (Quarter) stood at $1.0 million in 2021, then fell by 11.81% to $900878.4 in 2022, then decreased by 4.22% to $862903.8 in 2023, then surged by 119.81% to $1.9 million in 2024, then soared by 80.96% to $3.4 million in 2025.
- Its Receivables Refunds was $3.4 million in Q3 2025, compared to $3.1 million in Q2 2025 and $1.7 million in Q1 2025.